75 drugs reach their earliest generic-entry date in 2039

Jan 2039 · 14

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Camcevi Etm leuprolide mesylate	leuprolide mesylate	Accord	219745	1 Jan 2039	patent
Camcevi Kit leuprolide mesylate	leuprolide mesylate	Accord	211488	1 Jan 2039	patent
Filsuvez birch triterpenes	birch triterpenes	Chiesi	215064	4 Jan 2039	patent
Trudhesa dihydroergotamine mesylate	dihydroergotamine mesylate	Impel Pharms	213436	4 Jan 2039	patent, carve-out possible
Emrosi minocycline hydrochloride	minocycline hydrochloride	Journey	219015	7 Jan 2039	patent, carve-out possible
Eohilia budesonide	budesonide	Takeda Pharms Usa	213976	10 Jan 2039	patent
Focinvez fosaprepitant dimeglumine	fosaprepitant dimeglumine	Steriscience	216686	11 Jan 2039	patent
Elcys cysteine hydrochloride	cysteine hydrochloride	Exela Pharma	210660	15 Jan 2039	patent
Voranigo · 2 strengths vorasidenib	vorasidenib	Servier	218784	16 Jan 2039	patent
Lutathera lutetium lu-177 dotatate	lutetium lu-177 dotatate	Aaa Usa Inc	208700	25 Jan 2039	patent
Zejula · 3 strengths niraparib tosylate	niraparib tosylate	Glaxosmithkline	214876	25 Jan 2039	patent
Ekterly sebetralstat	sebetralstat	Kalvista	219301	26 Jan 2039	patent
Zegfrovy · 2 strengths sunvozertinib	sunvozertinib	Dizal	219839	28 Jan 2039	patent
Contepo fosfomycin disodium	fosfomycin disodium	Meitheal	212271	30 Jan 2039	patent, carve-out possible

Feb 2039 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Ozempic · 3 strengths semaglutide	semaglutide	Novo	213051	1 Feb 2039	patent
Wegovy · 4 strengths semaglutide	semaglutide	Novo	218316	1 Feb 2039	patent
Neffy · 2 strengths epinephrine	epinephrine	Ars Pharms Operation	214697	6 Feb 2039	patent
Combogesic acetaminophen; ibuprofen	acetaminophen; ibuprofen	Aft Pharms Us	209471	27 Feb 2039	patent
Nuplazid pimavanserin tartrate	pimavanserin tartrate	Acadia Pharms Inc	210793	27 Feb 2039	patent

Mar 2039 · 8

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Pokonza potassium chloride	potassium chloride	Genus Lifesciences	206814	7 Mar 2039	patent
Potassium Chloride · 2 strengths potassium chloride	potassium chloride	Genus Lifesciences	206814	7 Mar 2039	patent
Nouress cysteine hydrochloride	cysteine hydrochloride	Baxter Hlthcare Corp	212535	15 Mar 2039	patent
Wynzora betamethasone dipropionate; calcipotriene	betamethasone dipropionate; calcipotriene	Mc2	213422	18 Mar 2039	patent
Adrenalin · 5 strengths epinephrine	epinephrine	Ph Health	215875	21 Mar 2039	patent
Khapzory levoleucovorin	levoleucovorin	Acrotech Biopharma	211226	25 Mar 2039	patent
Nurtec Odt rimegepant sulfate	rimegepant sulfate	Pfizer	212728	25 Mar 2039	patent
Dhivy carbidopa; levodopa	carbidopa; levodopa	Avion Pharms	214869	28 Mar 2039	patent

Apr 2039 · 9

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Aristada · 4 strengths aripiprazole lauroxil	aripiprazole lauroxil	Alkermes Inc	207533	6 Apr 2039	patent, carve-out possible
Aristada Initio Kit aripiprazole lauroxil	aripiprazole lauroxil	Alkermes Inc	209830	6 Apr 2039	patent, carve-out possible
Vabomere meropenem; vaborbactam	meropenem; vaborbactam	Rempex	209776	6 Apr 2039	patent, carve-out possible
Retevmo · 2 strengths selpercatinib	selpercatinib	Eli Lilly And Co	213246	10 Apr 2039	patent
Retevmo · 4 strengths selpercatinib	selpercatinib	Eli Lilly And Co	218160	10 Apr 2039	patent
Katerzia amlodipine benzoate	amlodipine benzoate	Azurity	211340	11 Apr 2039	patent
Jatenzo · 3 strengths testosterone undecanoate	testosterone undecanoate	Tolmar	206089	12 Apr 2039	patent, carve-out possible
Norepinephrine Bitartrate In 0.9% Sodium Chloride · 4 strengths norepinephrine bitartrate	norepinephrine bitartrate	Inforlife	215700	26 Apr 2039	patent
Beqalzi · 4 strengths sonrotoclax	sonrotoclax	Beone Medicines Usa	220711	29 Apr 2039	patent

May 2039 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Cuvrior trientine tetrahydrochloride	trientine tetrahydrochloride	Orphalan	215760	3 May 2039	patent
Iheezo chloroprocaine hydrochloride	chloroprocaine hydrochloride	Harrow Eye	216227	14 May 2039	patent
Lumason sulfur hexafluoride lipid-type a microspheres	sulfur hexafluoride lipid-type a microspheres	Bracco	203684	15 May 2039	patent
Angiomax Rtu bivalirudin	bivalirudin	Maia Pharms Inc	211215	20 May 2039	patent

Jun 2039 · 6

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Tibsovo ivosidenib	ivosidenib	Servier	211192	7 Jun 2039	patent, carve-out possible
Brexafemme ibrexafungerp citrate	ibrexafungerp citrate	Glaxosmithkline	214900	10 Jun 2039	patent, carve-out possible
Imbruvica ibrutinib	ibrutinib	Pharmacyclics Llc	217003	14 Jun 2039	patent
Rytelo · 2 strengths imetelstat sodium	imetelstat sodium	Geron	217779	16 Jun 2039	patent, carve-out possible
Xcopri · 6 strengths cenobamate	cenobamate	Sk Life	212839	16 Jun 2039	patent, carve-out possible
Annovera ethinyl estradiol; segesterone acetate	ethinyl estradiol; segesterone acetate	Mayne Pharma	209627	21 Jun 2039	patent

Jul 2039 · 8

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Pedmark sodium thiosulfate	sodium thiosulfate	Fennec Pharms Inc	212937	1 Jul 2039	patent
Inluriyo imlunestrant tosylate	imlunestrant tosylate	Eli Lilly And Co	218881	11 Jul 2039	patent
Spy Agent Green Kit indocyanine green	indocyanine green	Novadaq Tech	211580	14 Jul 2039	patent
Omlonti omidenepag isopropyl	omidenepag isopropyl	Ocuvex Therap	215092	16 Jul 2039	patent, carve-out possible
Rocuronium Bromide rocuronium bromide	rocuronium bromide	B Braun Medical	219108	22 Jul 2039	patent
Zepbound · 12 strengths tirzepatide	tirzepatide	Eli Lilly And Co	217806	22 Jul 2039	patent, carve-out possible
Zepbound (Autoinjector) · 6 strengths tirzepatide	tirzepatide	Eli Lilly And Co	217806	22 Jul 2039	patent, carve-out possible
Zepbound Kwikpen · 6 strengths tirzepatide	tirzepatide	Eli Lilly And Co	217806	22 Jul 2039	patent, carve-out possible

Aug 2039 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Attruby acoramidis hydrochloride	acoramidis hydrochloride	Bridgebio Pharma	216540	16 Aug 2039	patent
Myhibbin mycophenolate mofetil	mycophenolate mofetil	Azurity	216482	16 Aug 2039	patent
Sotalol Hydrochloride sotalol hydrochloride	sotalol hydrochloride	Altathera Pharms Llc	022306	21 Aug 2039	patent, carve-out possible
Brekiya (Autoinjector) dihydroergotamine mesylate	dihydroergotamine mesylate	Amneal	215400	24 Aug 2039	patent

Sep 2039 · 4

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Baqsimi glucagon	glucagon	Amphastar Pharms Inc	210134	23 Sep 2039	patent
Erzofri · 6 strengths paliperidone palmitate	paliperidone palmitate	Luye Innomind Pharma	216352	24 Sep 2039	patent, carve-out possible
Inrebic fedratinib hydrochloride	fedratinib hydrochloride	Bristol-Myers	212327	24 Sep 2039	patent, carve-out possible
Zenbexus · 2 strengths iberdomide hydrochloride	iberdomide hydrochloride	Bristol Myers Squibb	221075	30 Sep 2039	patent, carve-out possible

Oct 2039 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Likmez metronidazole	metronidazole	Saptalis Pharms	216755	4 Oct 2039	patent
Xofluza · 2 strengths baloxavir marboxil	baloxavir marboxil	Genentech Inc	210854	9 Oct 2039	patent
Yupelri revefenacin	revefenacin	Mylan Ireland Ltd	210598	23 Oct 2039	patent, carve-out possible
Ryzumvi phentolamine mesylate	phentolamine mesylate	Famygen Life Sci	217064	25 Oct 2039	patent, carve-out possible
Cobenfy · 3 strengths trospium chloride; xanomeline tartrate	trospium chloride; xanomeline tartrate	Bristol-Myers	216158	29 Oct 2039	patent

Nov 2039 · 5

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Fotivda · 2 strengths tivozanib hydrochloride	tivozanib hydrochloride	Aveo Pharms	212904	5 Nov 2039	patent, carve-out possible
Lytgobi futibatinib	futibatinib	Taiho Oncology	214801	5 Nov 2039	patent
Zurnai (Autoinjector) nalmefene hydrochloride	nalmefene hydrochloride	Knoa Pharma	218590	5 Nov 2039	patent
Rezlidhia olutasidenib	olutasidenib	Rigel Pharms	215814	12 Nov 2039	patent
Tavneos avacopan	avacopan	Chemocentryx	214487	27 Nov 2039	patent

Dec 2039 · 3

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Upneeq oxymetazoline hydrochloride	oxymetazoline hydrochloride	Rvl Pharms	212520	16 Dec 2039	patent
Vtama tapinarof	tapinarof	Organon Llc	215272	18 Dec 2039	patent, carve-out possible
Orlynvah probenecid; sulopenem etzadroxil	probenecid; sulopenem etzadroxil	Iterum Therap	213972	23 Dec 2039	patent